Interpace Biosciences Inc EBIT margin
Что обозначает EBIT margin в Interpace Biosciences Inc?
EBIT margin Interpace Biosciences Inc является -1.56%
Какое определение для EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin компаний в Health Care сектор на NASDAQ по сравнению с Interpace Biosciences Inc
Что делает Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Компании с ebit margin похож на Interpace Biosciences Inc
- DSP имеет EBIT margin из -1.61%
- China XD Plastics Co Ltd имеет EBIT margin из -1.60%
- Hinduja Ventures имеет EBIT margin из -1.58%
- Hudson Global Inc имеет EBIT margin из -1.58%
- Zenith Exports имеет EBIT margin из -1.58%
- Century Enka имеет EBIT margin из -1.57%
- Interpace Biosciences Inc имеет EBIT margin из -1.56%
- Douyu International Ltd имеет EBIT margin из -1.55%
- Orient Press имеет EBIT margin из -1.55%
- Cato имеет EBIT margin из -1.54%
- Softing AG имеет EBIT margin из -1.53%
- Yunhong CTI Ltd имеет EBIT margin из -1.52%
- CareRx имеет EBIT margin из -1.52%